Custom Search


Portfolio of Big Pharma and Biotech Cancer Immunotherapy Stocks

Here are 10 big pharma and big biotech cancer immunotherapy stocks.

Portfolio of Big Pharma and Biotech Cancer Immunotherapy Stocks
Stock
Price Quote & Dividend
1-Yr Price Chart
Amgen
AstraZeneca
Bristol-Myers Squibb
Celgene
Gilead Sciences
Incyte Corporation
Merck
Nektar Therapeutics
Novartis
Pfizer
Price and dividend data from Quandl.


To inspect the performance of the Portfolio of Big Pharma and Biotech Cancer Immunotherapy Stocks portfolio, see the returns table and chart below. Portfolio values are computed using monthly closes for from Quandl.

All 10 are included in the portfolio computations. The current value of the portfolio assumes that $1,000.00 was invested (total of $10,000) in each at its closing weekly price for the current date in 2008.


Portfolio of Big Pharma and Biotech Cancer Immunotherapy Stocks - Return Results
Portfolio:
Portfolio of Big Pharma and Biotech Cancer Immunotherapy Stocks
Start date:
Apr-24-2008
Start value:
$10,000
End date:
Apr-24-2018
End value:
$48,231
Number prices
121
Minimum value occurred on Feb-28-2009
$7,634
Maximum value occurred on Mar-31-2018
$54,388
Total gain or loss (Start date to End date)
382.31%
Annualized gain or loss (Start date to End date)
17.04%
Total dollar value on End date of a $10,000 purchase made on Start date
$48,231
Average percent return for all possible buy/sell combinations
108.43%
Number returns
7,260
Number profitable returns (Winners)
6,674
Percent profitable returns
91.93%
Number unprofitable returns (Losers)
586
Percent unprofitable returns
8.07%
Winners to losers ratio
11.39
Stock Return Calculator






Related Articles

Portfolio of Big Pharmaceuticals Stocks: Cancer
Portfolio of Biotech Stocks: Cancer
Portfolio of Cancer Immunotherapy Stocks
Portfolio of Immune Checkpoint Inhibitor Stocks